Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Lancet Oncol. 2014 Jan 16;15(2):156–163. doi: 10.1016/S1470-2045(13)70589-8

Figure 2.

Figure 2

Kaplan-Meier Curves of Disease-free Survival and Overall Survival According to Assigned Treatment Group for All Patients (panels A and B), and for ER-negative (panels C and D) and ER-positive (panels E and F) Cohorts. The median follow-up was 4·9 years.